Trump administration

;

Trump budget proposes over $1.5 billion cut to domestic HIV programs

Apr 3, 2026

Congress rejected these massive attacks on HIV prevention last year and we will urge them to do the same again this year. While we are reassured that over 600,000 low-income people currently accessing care and treatment through the Ryan White HIV/AIDS Program and those using PrEP programs in community health centers can maintain their services, the dismantling of HIV prevention and surveillance and other programs will just lead to more HIV infections and higher health costs down the road.

read more

Trump administration fails to take steps to lower patient costs for prescription drugs

Feb 9, 2026

In the 2027 Notice of Benefit and Payment Parameters rule proposed today, the administration failed to include promised new regulations on whether copay assistance will count towards patient cost-sharing. “Every day this rule is delayed is another day that insurers and PBMs are pocketing billions of dollars meant for patients who are struggling to afford their drugs,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We know that President Trump is squarely focused on drug affordability, and while we are extremely disappointed that this simple step was not yet taken, we urge the administration to act in the very near future.”

read more

TrumpRx Shakes Up Drug Pricing by Bypassing Middlemen

Feb 5, 2026

Today marks a monumental step in transforming drug pricing and making prescription drugs more affordable for the American people, particularly for those without insurance. For those who do have insurance, TrumpRx may not always be the best option. We hope consumers clearly understand this and urge the Trump administration to expand the site and work with insurers so that TrumpRx payments are counted by insurers. Frankly, if people who have health insurance are using TrumpRx, it demonstrates that the insurer is failing to meet the needs of its paying consumers.

read more

Congress funds domestic HIV programs—Trump administration must now implement them

Jan 20, 2026

After a tumultuous year of proposed program cuts and eliminations, Congress has agreed to reject them and instead has maintained funding for domestic HIV prevention and treatment programs on a bipartisan basis. Now, the Trump administration must focus its attention on properly implementing these programs in order to get the nation back on track to end HIV in the U.S.

read more

House Republicans Go Way Beyond President’s Budget by Ending all HIV Prevention & Slash AIDS Care by 20%

Sep 1, 2025

This is not a bill for making America healthy again, but a disastrous bill that will reignite HIV in the United States. We urge Congress to reject these reckless cuts. Eliminating all HIV prevention means the end of state and local testing and surveillance programs, educational programs, and linkage to lifesaving care and treatment, along with PrEP. It will translate into an increased number of new HIV infections, which will be costlier to treat in the long run. At a time when we have the tools to prevent HIV, including new long-acting forms of PrEP, we must not abandon the bipartisan progress our nation has made in combatting HIV.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest